Videos

ChemoTech | Mohan Frick, CEO

ChemoTech is dedicated to innovation in cancer care and recently launched IQwave. This technology performs electrochemotherapy which is approved for the treatment of a wide range of tumors.

Early Detection | Kim Vanderlinden, CEO

Early Detection is focused on detecting cancer at its earliest stages - while the tissue is still considered precancerous.

MagForce USA | Ben Lipps, CEO

Nanotechnology-based therapy for the treatment of cancer.

Siva Therapeutics | Len Pagliaro, CEO

SIVA Therapeutics' mission is to develop minimally invasive devices for cancer treatment.

Endoluxe | Devon Bream, CEO

Endoluxe is a world-class wireless endoscopic video imaging organization launching its industry design award-winning Endoluxe EVS Orb.

Patheous Health | Michael Peck, CEO

Patheous Integrated Dysphagia Care (iDC) helps seniors and senior care providers diagnose and treat the dysphagia episode of care through the coordinated use of our patented remote patient monitoring technology, mobile imaging diagnostics, evidence-base therapeutic applications and nutrition coaching applications.

Rapid Nexus | Dr. Margaret Kalmeta, CEO & Founder

Rapid Nexus has developed a first of its kind nanotechnology wound dressing, along with devices that accelerate healing, to rapidly close chronic non-healing wounds.

Centese | Randy Preston, Chief Business Officer

Transforming surgical drainage with intelligent digital devices to reduce complications and costs in patients recovering from cardiothoracic surgery.

StaplCam | Dinesh Vyas, CEO

World’s first fully disposable, single-incision laparoscopic surgical device with multiple integrated technologies: stapler, grasper and dual-camera with in-line digital display for multiple common surgeries for faster surgery, quick recovery from single small hole and shorter anesthesia.

Moray Medical | Mark Barrish, CEO

Moray Medical is harnessing robotics to democratize edge-to-edge mitral valve repair. The company's initial product is the Coral system, which will combine augmented reality (AR) visualization, a digital user interface, and microfluidics to simplify mitral valve repair procedures.

CorInnova | William Altman, President & CEO

CorInnova is developing a minimally invasive, soft robotic cardiac device for the short-term treatment of acute heart failure.

Nyra Medical | Murali Padala, CEO & Founder

Nyra Medical is developing an image-guided, catheter-based intervention, called the cardiac leaflet enhancer (CARLEN), for the treatment of mitral and/or tricuspid regurgitation in heart failure patients.

Synova Life Sciences | John Chi, CEO

Synova Life Sciences a biotechnology company that has developed a proprietary methodology and system for processing fat cells into autologous stem cells.

Bone Health Technologies | Laura Yecies, CEO

Bone Health Technologies is developing OsteoBoost, a wearable belt that applies mechanical stimulation to the user in order to reduce bone loss and encourage bone growth in the hips and spine.

Access Vascular | James Biggins, President & CEO

Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access.

Strados Labs | Nick Delmonico, President & CEO

User-friendly sensors, unique collection methodologies, and data processing software that creates a more holistic view of a patient's respiratory health.

Mindera Health | George Mahaffey, CEO

Mindera's SkinAtlas is a scalable platform that leverages artificial intelligence and machine learning to analyze patient-specific data collected from a dermal biomarker patch.

True Digital Surgery | September Riharb

True Digital Surgery develops next-generation solutions for the operating room. The company's flagship system, Occipta, is a heads-up, digital mircoscope and imaging platform intended to improve surgeons' control and visualization capabilities during reconstructive surgery.